# Hologic, Inc. clinical trials: 28 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials with Hologic, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Hologic, Inc.: 28 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/hologic-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 10, 2024 | NCT06636539 | Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device | Hologic, Inc. | Not applicable | Active not recruiting | Breast Screening | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06636539) |
| January 20, 2022 | NCT05199701 | Prospective Case Collection Study for New Mammography Technologies | Hologic, Inc. | Not applicable | Active not recruiting | Mammography | 7,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05199701) |
| December 17, 2020 | NCT04671329 | A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy | Hologic, Inc. | Not applicable | Completed | Breast Cancer | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04671329) |
| May 29, 2020 | NCT04408352 | RF Ablation of the Trigone for the Treatment of UUI | Hologic, Inc. | Not applicable | Suspended | Urgent Urinary Incontinence | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04408352) |
| August 2, 2018 | NCT03611543 | Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle | Hologic, Inc. | Observational | Completed | Breast Cancer | 443 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03611543) |
| April 13, 2018 | NCT03497234 | Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test | Hologic, Inc. | Not applicable | Withdrawn | Intra-Amniotic Infection of Foetus | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03497234) |
| March 7, 2018 | NCT03456583 | Brevera™ Breast Biopsy System Data Collection Study | Hologic, Inc. | Observational | Completed | Breast Cancer Female | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03456583) |
| October 3, 2017 | NCT03300206 | A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System | Hologic, Inc. | Observational | Completed | Breast Cancer Female | 525 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03300206) |
| June 10, 2016 | NCT02795975 | Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples | Hologic, Inc. | Observational | Terminated | Chlamydia Trachomatis, Gonorrhea | 1,766 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02795975) |
| October 21, 2014 | NCT02270099 | Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects | Hologic, Inc. | Observational | Completed | Herpes Simplex Infections | 839 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02270099) |
| June 18, 2014 | NCT02167113 | Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay | Hologic, Inc. | Observational | Completed | Hepatitis B, Chronic | 331 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02167113) |
| February 21, 2014 | NCT02068963 | Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing | Hologic, Inc. | Observational | Completed | Hepatitis C | 352 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02068963) |
| October 7, 2013 | NCT01955148 | fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth | Hologic, Inc. | Observational | Unknown | Pre-term Birth | 1,210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01955148) |
| September 4, 2013 | NCT01934244 | Post Approval NovaSure Essure Labeling Study | Hologic, Inc. | Observational | Unknown | Menorrhagia | 318 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01934244) |
| September 14, 2011 | NCT01433640 | Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study | Hologic, Inc. | Observational | Completed | Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01433640) |
| June 9, 2011 | NCT01369758 | MyoSure Hysteroscopic Tissue Removal System Registry Study | Hologic, Inc. | Not applicable | Completed | Uterine Fibroids, Polyps | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01369758) |
| August 9, 2010 | NCT01177670 | Adiana Post-Approval Clinical Study (APACS) | Hologic, Inc. | Observational | Terminated | Women Contraception | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01177670) |
| June 29, 2010 | NCT01152112 | HOME Study: Hysteroscopic Office Myomectomy Evaluation | Hologic, Inc. | Not applicable | Completed | Uterine Fibroids, Polyps | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01152112) |
| December 4, 2009 | NCT01026805 | Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator | Hologic, Inc. | Observational | Completed | Abnormal Uterine Bleeding, Infertility | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01026805) |
| October 6, 2009 | NCT00990483 | A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast Abnormalities | Hologic, Inc. | Not applicable | Completed | Breast Cancer | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00990483) |
| September 18, 2009 | NCT00979342 | Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System | Hologic, Inc. | Not applicable | Completed | Uterine Fibroids, Polyps | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00979342) |
| September 3, 2009 | NCT00971087 | Multicenter Hologic Tomosynthesis Study | Hologic, Inc. | Not applicable | Completed | Breast Cancer | 3,521 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00971087) |
| April 17, 2009 | NCT00883324 | Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum | Hologic, Inc. | Observational | Completed | Preterm Delivery | 329 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00883324) |
| September 25, 2008 | NCT00759447 | A Pilot Study - Comparison of Two Hologic 3D Mammography Systems | Hologic, Inc. | Observational | Completed | Breast Cancer | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00759447) |
| September 18, 2008 | NCT00754598 | Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography | Hologic, Inc. | Not applicable | Completed | Breast Cancer | 1,183 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00754598) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 2 |
| Not applicable | 12 |
| Observational | 14 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Terminated | 3 |
| Unknown | 2 |
| Active not recruiting | 2 |
| Withdrawn | 1 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 7 |
| Leiomyoma | 4 |
| Polyps | 3 |
| Agnosia | 2 |
| Gonorrhea | 1 |
| Herpes Simplex | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Hepatitis C | 1 |
| Brain Neoplasms | 1 |
| Hepatitis B, Chronic | 1 |
| Metrorrhagia | 1 |
| Infertility | 1 |
| Menorrhagia | 1 |
| Premature Birth | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B science and technology companies in the United States](https://specstream.ai/data/businesses/b2b-science-and-technology-companies/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Vegetarian restaurants in the United States](https://specstream.ai/data/businesses/vegetarian-restaurants/united-states)
- [Ferry boat companies in the United States](https://specstream.ai/data/businesses/ferry-boat-companies/united-states)
- [Rheumatology practices in the United States](https://specstream.ai/data/businesses/rheumatology-practices/united-states)
- [Collection agencies in the United States](https://specstream.ai/data/businesses/collection-agencies/united-states)
